2-Pyrrolidone

2-Pyrrolidone

SCHEMBL887016

CC(=O)N(C)C.O=C1CCCN1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
OR51E2 Q9H255 1/20 0.62
CRBN Q96SW2 3/20 0.54
FKBP5 Q13451 1/20 0.54
KDM4E B2RXH2 2/20 0.39
GAA P10253 1/20 0.39
POLB P06746 1/20 0.39
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
GFER P55789 1/20 0.33
KMT2A Q03164 1/20 0.33
PARP1 P09874 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
LMNA P02545 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Pyrrolidone SCHEMBL9795967 0.88 OR51E2 (0.62) OR51E2CRBNFKBP5KDM4EGAA
2-Pyrrolidone SCHEMBL17698402 0.87 OR51E2 (0.75) OR51E2CRBNFKBP5KDM4EGAA
2-Pyrrolidone SCHEMBL2155488 0.85 OR51E2 (0.71) OR51E2CRBNFKBP5KDM4EGAA
2-Pyrrolidone SCHEMBL27878798 0.84 OR51E2 (0.79) OR51E2CRBNFKBP5KDM4EGAA
2-Pyrrolidone SCHEMBL3729403 0.83 OR51E2 (0.68) OR51E2CRBNFKBP5KDM4EGAA
2-Pyrrolidone SCHEMBL27605240 0.83 OR51E2 (0.68) OR51E2CRBNFKBP5KDM4EGAA
2-Pyrrolidone SCHEMBL1436788 0.82
2-Pyrrolidone SCHEMBL27555931 0.81 OR51E2 (0.65) OR51E2CRBNFKBP5KDM4EGAA
2-Pyrrolidone SCHEMBL27544296 0.81 OR51E2 (0.65) OR51E2CRBNFKBP5KDM4EGAA
2-Pyrrolidone SCHEMBL28180524 0.81 OR51E2 (0.65) OR51E2CRBNFKBP5KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170204062-A1 PROCESS FOR THE PREPARATION OF REGORAFENIB AND ITS CRYSTALLINE FORMS SHILPA MEDICARE LIMITED (IN) 2017-07-20 US claimed
EP-2833867-A1 SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS Intervet International B.V. (NL) 2015-02-11 EP claimed
WO-2013150055-A1 SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS INTERVET INTERNATIONAL B.V. (NL) 2013-10-10 WO claimed
US-20110088511-A1 METHOD FOR PRODUCING ROD-SHAPED AND BRANCHED METALLIC NANO-STRUCTURES BY POLYOL COMPOUNDS JALALEDIN GHANAVI 2011-04-21 US claimed
CN-1013867-B PHOTOSTABLE POLYPARA-PHENYL-DIFORMYL PARAPHENYL-DIAMINE FIBER AND ITS SYNTHESIS UNIV CHINA TEXTILE (CN) 1991-09-11 CN claimed
US-20200306836-A1 METHODS FOR THE PRODUCTION OF SILVER NANOWIRES BASF SE (DE) 2020-10-01 US disclosed
CN-109628005-B Wireless charging ultra-thin black covering film and preparation method thereof 深圳市弘海电子材料技术有限公司 2019-10-18 CN disclosed
CN-110139878-A Method for making crosslinked polymer 索尔维特殊聚合物意大利有限公司 2019-08-16 CN disclosed
CN-104470852-B The mixed-metal oxides of fluorinated ion-exchange polymer are used for as scavenger SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2019-07-16 CN disclosed
CN-109971340-A A kind of antistatic antirust covers the preparation method of iron film 常州市贝特织造有限公司 2019-07-05 CN disclosed
CN-108137965-A Emulsion composition for ink and water-based ink 日本化药株式会社 2018-06-08 CN disclosed
US-20170355023-A1 METHODS FOR THE PRODUCTION OF SILVER NANOWIRES BASF SE (DE) 2017-12-14 US disclosed
US-5096991-A Monomer from dihydroxy aromatic compound and haloalkylsilanol, elasticity, strength SHIN-ETSU CHEMICAL CO., LTD. (JP) 1992-03-17 US disclosed
CN-1013867-B PHOTOSTABLE POLYPARA-PHENYL-DIFORMYL PARAPHENYL-DIAMINE FIBER AND ITS SYNTHESIS UNIV CHINA TEXTILE (CN) 1991-09-11 CN disclosed
EP-0483143-A4 MEMBRANE AFFINITY APPARATUS AND PURIFICATION METHODS RELATED THERETO. SEPRACOR INC (US) 1991-07-24 EP disclosed
WO-1990005018-A1 MEMBRANE AFFINITY APPARATUS AND PURIFICATION METHODS RELATED THERETO SEPRACOR, INC. (US) 1990-05-17 WO disclosed
CN-1036965-A HIGHLY SOLUBLE AROMATIC POLYIMIDES DU PONT (US) 1989-11-08 CN disclosed
CN-1036777-A Photostabilization Fanglun 1414 and synthetic UNIV CHINA TEXTILE (CN) 1989-11-01 CN disclosed
US-4187365-A FROM POLYISOCYANATE, FORMIC ACID, AND DICARBOXYLIC ANHYDRIDE CONTAINING ANOTHER ACID GROUP BAYER AKTIENGESELLSCHAFT (DE) 1980-02-05 US disclosed
US-4097538-A TREATING WITH LIQUID AMMONIA GENERAL ELECTRIC COMPANY (US) 1978-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170204062-A1 PROCESS FOR THE PREPARATION OF REGORAFENIB AND ITS CRYSTALLINE FORMS BRAF, ALK, NRAS OR51E2 3520/4885CRBN 486/4885FKBP5 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.